
Peyton Howell
@peytonrhowell
Chief Operating & Growth Officer @Parexel. Patient access to new innovative treatments is my passion. Opinions are my own.
ID: 2373109236
05-03-2014 03:46:43
626 Tweet
766 Takipçi
1,1K Takip Edilen



How can we elevate the patient voice to improve outcomes in cell and gene therapy studies? Kristina Reeder shares details with Stacy Hurt (she/her)🌻 about her presentations at #ISCT2023 —one spotlighting cancer patients’ lived experiences on their pathway to CAR-T cell trial participation.


We are proudly partnering with Leukemia and Lymphoma Society (SOU) (LLS) as the 2023 Presenting Sponsor of Survivorship and Hope for the Triangle, NC and a corporate sponsor for Boston! Peyton Howell, COO, is also serving as Executive Leadership Council Chair for the LLS Triangle #LighttheNight Walk!

Grateful for patient advocates and cancer survivors like Stacy Hurt (she/her)🌻 here at #ASCO23 #patientsfirst #clinicaltrials


Last week Parexel colleagues gathered to enjoy food and games while raising funds for The Leukemia & Lymphoma Society. Parexel is proud to be a corporate sponsor for the Boston #LighttheNight walk in October and we're challenging ourselves to exceed our fundraising goals in the lead-up to the big night!



Congratulations Stacy Hurt (she/her)🌻 for being named a 2023 #Fierce50 honoree — spotlighting trailblazers who have pioneered groundbreaking therapies, overhauled patient care models and spearheaded innovative approaches to address the most pressing challenges in biopharma and healthcare.




Chief Operating and Growth Officer Peyton Howell spoke to Applied Clinical Trials about her panel at the #JPMorganHealth conference on the potential of tech like AI and machine learning as well as the increasing importance of the patient voice in clinical trial design. #PatientsFirst



This year's #WorldHealthDay theme champions everyone's right to healthcare, yet many patients are underrepresented in clinical research. This research paper by Duke-Margolis, partly informed by Parexel's experts, explores how RWD/E can address such healthcare disparities.

Parexel is proud to announce that Teri Karcher, Ph.D., has been named to the 2024 PharmaVoice 100 list of inspirational leaders in the #LifeSciences industry! Join us in congratulating Teri and read what CEO Peyton Howell had to say in the press release.👇 #PharmaVoice100